In this issue of Hematology/Oncology Clinics, guest editor Dr. Jason K. Sicklick brings his considerable expertise to the topic of Precision Oncology and Cancer Surgery. Top experts discuss key topics in this fast-changing field, bridging medical and surgical care, helping to shape multidisciplinary treatment planning, and reflecting broader trends such as intraoperative molecular imaging and biomarker-driven therapy timing.
1. Cover image - p. i 2. Title page - p. i 3. Table of Contents - p. i 4. Copyright - p. ii 5. Contributors - p. iii 6. Forthcoming Issues - p. xi 7. Preface - p. xiii 8. Evolution of Precision Oncology, Personalized Medicine, and Molecular Tumor Boards - p. 685 9. Understanding the Landscape of Clinically Available Molecular Testing - p. 705 10. Cost-Effectiveness and the Economics of Genomic Testing and Molecularly Matched Therapies - p. 719 11. Tissue-Agnostic Cancer Therapy Approvals - p. 731 12. Immuno-Oncology: New Insights into Targets and Therapies - p. 751 13. Targeted Therapies, Biologics, and Immunotherapy in the Neoadjuvant and Adjuvant Settings: Perioperative Risks - p. 765 14. Precision Oncology in Breast Cancer Surgery - p. 779 15. Precision Oncology in Lung Cancer Surgery - p. 797 16. Precision Oncology in Gastrointestinal and Colorectal Cancer Surgery - p. 807 17. Precision Oncology in Hepatopancreatobiliary Cancer Surgery - p. 831 18. Precision Oncology in Melanoma and Skin Cancer Surgery - p. 857 19. Precision Oncology in Soft Tissue Sarcomas and Gastrointestinal Stromal Tumors - p. 875 20. Precision Oncology in Pediatric Cancer Surgery - p. 895 21. Current Multidisciplinary Lymphoma and Myeloma Management for Surgeons - p. 933
In this issue of Hematology/Oncology Clinics, guest editor Dr. Jason K. Sicklick brings his considerable expertise to the topic of Precision Oncology and Cancer Surgery. Top experts discuss key topics in this fast-changing field, bridging medical and surgical care, helping to shape multidisciplinary treatment planning, and reflecting broader trends such as intraoperative molecular imaging and biomarker-driven therapy timing.
1. Cover image - p. i 2. Title page - p. i 3. Table of Contents - p. i 4. Copyright - p. ii 5. Contributors - p. iii 6. Forthcoming Issues - p. xi 7. Preface - p. xiii 8. Evolution of Precision Oncology, Personalized Medicine, and Molecular Tumor Boards - p. 685 9. Understanding the Landscape of Clinically Available Molecular Testing - p. 705 10. Cost-Effectiveness and the Economics of Genomic Testing and Molecularly Matched Therapies - p. 719 11. Tissue-Agnostic Cancer Therapy Approvals - p. 731 12. Immuno-Oncology: New Insights into Targets and Therapies - p. 751 13. Targeted Therapies, Biologics, and Immunotherapy in the Neoadjuvant and Adjuvant Settings: Perioperative Risks - p. 765 14. Precision Oncology in Breast Cancer Surgery - p. 779 15. Precision Oncology in Lung Cancer Surgery - p. 797 16. Precision Oncology in Gastrointestinal and Colorectal Cancer Surgery - p. 807 17. Precision Oncology in Hepatopancreatobiliary Cancer Surgery - p. 831 18. Precision Oncology in Melanoma and Skin Cancer Surgery - p. 857 19. Precision Oncology in Soft Tissue Sarcomas and Gastrointestinal Stromal Tumors - p. 875 20. Precision Oncology in Pediatric Cancer Surgery - p. 895 21. Current Multidisciplinary Lymphoma and Myeloma Management for Surgeons - p. 933
